Cargando…
Therapeutic targeting of mineralocorticoid receptors in pulmonary hypertension: Insights from basic research
Pulmonary hypertension (PH) is characterized by pulmonary vascular remodeling and associated with adverse outcomes. In patients with PH, plasma aldosterone levels are elevated, suggesting that aldosterone and its receptor, the mineralocorticoid receptor (MR), play an important role in the pathophysi...
Autores principales: | Mamazhakypov, Argen, Lother, Achim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922727/ https://www.ncbi.nlm.nih.gov/pubmed/36793473 http://dx.doi.org/10.3389/fcvm.2023.1118516 |
Ejemplares similares
-
The Role of G Protein-Coupled Receptors in the Right Ventricle in Pulmonary Hypertension
por: Viswanathan, Gayathri, et al.
Publicado: (2018) -
Mineralocorticoid Receptor Antagonists Therapy in Resistant Hypertension: Time to Implement Guidelines!
por: Maiolino, Giuseppe, et al.
Publicado: (2015) -
Osteopontin in Pulmonary Hypertension
por: Mamazhakypov, Argen, et al.
Publicado: (2023) -
Cardiac Mineralocorticoid Receptor and the Na(+)/H(+) Exchanger: Spilling the Beans
por: Ennis, Irene Lucía, et al.
Publicado: (2021) -
Novel Therapeutic Targets for the Treatment of Right Ventricular Remodeling: Insights from the Pulmonary Artery Banding Model
por: Mamazhakypov, Argen, et al.
Publicado: (2021)